Atlas Trials

Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.

Clinical trial NCT04654702 · COMPLETED

Trial details

NCT number
NCT04654702
Sponsor
Hanmi Pharmaceutical Company Limited
Status
COMPLETED
Study type
OBSERVATIONAL
Perennial Allergic RhinitisAsthma
Start date
2017-11-17
Primary completion
2020-01-10
Enrollment
2671

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.